BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9209381)

  • 1. Role of p53 tumor suppressor gene and Fas/Apo-1 in induction of apoptosis and differentiation of cancer cells.
    Takahashi R
    Leukemia; 1997 Apr; 11 Suppl 3():331-3. PubMed ID: 9209381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer.
    Boldrini L; Faviana P; Pistolesi F; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Fontanini G
    Oncogene; 2001 Oct; 20(45):6632-7. PubMed ID: 11641789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
    Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
    Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.
    Tamura T; Aoyama N; Saya H; Haga H; Futami S; Miyamoto M; Koh T; Ariyasu T; Tachi M; Kasuga M
    Oncogene; 1995 Nov; 11(10):1939-46. PubMed ID: 7478511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 promotes selection for Fas-mediated apoptotic resistance.
    Maecker HL; Koumenis C; Giaccia AJ
    Cancer Res; 2000 Aug; 60(16):4638-44. PubMed ID: 10969818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.
    Sheard MA; Uldrijan S; Vojtesek B
    Cancer Res; 2003 Nov; 63(21):7176-84. PubMed ID: 14612511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment.
    Kobayashi T; Ruan S; Jabbur JR; Consoli U; Clodi K; Shiku H; Owen-Schaub LB; Andreeff M; Reed JC; Zhang W
    Cell Death Differ; 1998 Jul; 5(7):584-91. PubMed ID: 10200513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of p53 and Fas/CD95 in murine neural progenitor cell response to ionizing irradiation.
    Semont A; Nowak EB; Silva Lages C; Mathieu C; Mouthon MA; May E; Allemand I; Millet P; Boussin FD
    Oncogene; 2004 Nov; 23(52):8497-508. PubMed ID: 15361846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated.
    McKenzie PP; Guichard SM; Middlemas DS; Ashmun RA; Danks MK; Harris LC
    Clin Cancer Res; 1999 Dec; 5(12):4199-207. PubMed ID: 10632361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC; López-Rivas A
    Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation.
    Goi K; Takagi M; Iwata S; Delia D; Asada M; Donghi R; Tsunematsu Y; Nakazawa S; Yamamoto H; Yokota J; Tamura K; Saeki Y; Utsunomiya J; Takahashi T; Ueda R; Ishioka C; Eguchi M; Kamata N; Mizutani S
    Cancer Res; 1997 May; 57(10):1895-902. PubMed ID: 9157982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis.
    Spierings DC; de Vries EG; Stel AJ; te Rietstap N; Vellenga E; de Jong S
    Oncogene; 2004 Jun; 23(28):4862-72. PubMed ID: 15122333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
    Burns TF; Bernhard EJ; El-Deiry WS
    Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
    Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
    Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
    Baptiste N; Friedlander P; Chen X; Prives C
    Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA; Khan T; Koul D; Lang FF; Conrad CA; Yung WK; Liu TJ
    Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.